Hypothesis: Site-specific variables that contribute to the pathogenesis of bronchopulmonary dysplasia (BPD) can be identified.
Introduction
With the advent of increased use of antenatal steroids and surfactant replacement therapy, there has been a remarkable decline in mortality in very low birth weight (VLBW) infants. 1 Despite this, there has been no measurable effect on the incidence of bronchopulmonary dysplasia (BPD). 1 BPD is a complex disorder with multiple environmental and genetic factors involved in its pathogenesis. 2 Furthermore, there have been controversies regarding disease definitions and management practices. 3 Some progress has been made in standardizing the definition of BPD, 4 but in spite of this, there continues to be center differences in the rate of BPD. 5 This raises the issue of variation in the management of the sick VLBW in different neonatal intensive care units (NICUs) and the potential impact on BPD.
We hypothesized that site-specific differences in the factors contributing to the pathogenesis of BPD can be identified by comprehensive analyses. Our goal in the present study was to evaluate two NICUs in terms of antenatal, perinatal and postnatal characteristics (including nutritional intake and growth) of VLBW infants at risk for developing BPD. In addition, we selected the two sites that were similar in size but served different populationsone catered to a predominant African-American inner city population whereas the other was in a suburban location with the majority being Caucasian. Thus, with the comprehensive analyses outlined above along with the specific selection of the population, we hoped to identify the 'environmental' factors as well any 'inherent' (genetic) differences that may be present in these two NICUs. In conducting this study, we felt that with a large sample size and the additional detailed collection of nutrition and growth data in two similar-sized NICUs that serve different populations, we could identify the site-specific factors contributing to BPD, with the hope that these could then be targeted as potential approaches for amelioration of BPD.
Materials and methods
Medical records of 306 infants (gestational age (GA) <30 weeks) who were born at Albert Einstein Medical Center, Philadelphia (site A) from 1993 to 1997 or at the Mercy Children's Hospital, Toledo, OH (site O) from 1997 to 2000, and who survived to at least 36 weeks postmenstrual age (PMA) were reviewed. Both are Level III NICUs of similar size and number of attending neonatologists. There were no significant changes in the essentially similar nutrition, ventilation and postnatal steroids (PNS) protocols at the two sites over 1993 to 2000. Early nasal continuous positive airway pressure (NCPAP), prophylactic surfactant or permissive hypercapnea was not used at either site during 1993 to 2000. Similar modes of ventilation (NCPAP, conventional, highfrequency jet) were available at both sites. The targeted oxygen saturation was 90 to 96% at both sites during 1993 to 2000. The study was approved by the institutional review boards at the respective institutions.
BPD was defined as the need for supplemental oxygen at 36 weeks PMA along with characteristic radiographic changes. 6 All eligible infants were included. Charts were reviewed for weights, total fluids, calories, carbohydrate, protein and fat intake at birth, 7, 14, 21, 28 days of life. Data were also collected about:
Maternal characteristics: (a) Race. (b) Antenatal steroid treatment was defined as at least a 12-h interval between maternal dosing and subsequent delivery of the infant. (c) Chorioamnionitis was defined as a positive culture from the amniotic fluid; in its absence, the presence of organisms on Gram stain or sheets of leukocytes or low glucose in the amniotic fluid in the presence of any two of the following clinical symptomatology -maternal fever (X381C), leukocytosis (X15 000/mm 3 ), uterine tenderness, pus from the cervix, fetal tachycardia (X160/min). (d) Pregnancyinduced hypertension (PIH) was defined as a maternal systolic blood pressure of >140 mm Hg and a diastolic pressure of >90 mm Hg in the presence of proteinuria (>300 mg/24 h) and nondependent edema. (e) History of maternal drug use was defined as use of cocaine, heroin or marijuana as per positive maternal/ infant urine screen.
The neonatal characteristics recorded for each infant were as follows: (a) GA at delivery which was based on either the date of the last menstrual period, a known date of conception, a fetal ultrasound before 20 weeks or the Ballard scoring system. In general, all infants were administered 80 to 100 ml/kg/day as 5 to 10% dextrose on the day of birth. Fluids were increased by 20 ml/kg/day to 140 to 160 ml/kg/day by day 5 of life. On day 2 of life, electrolytes were added and usually by day 3, TPN was begun. Amino acids (6% TrophAmine, B Braun Medical Inc., Irvine, CA, USA) were started at 0.5 to 1 gm/kg/day and intralipid (20% Liposyn III, Abbott Laboratories, North Chicago, IL, USA) at the same amount, the same or next day. Amino acids and intralipid were increased, as tolerated, by 0.5 to 1 gm/kg/day until a maximum of 2.5 to 3 gm/kg/day intake was achieved. When the infant was stable, small quantities of feeds (breast milk/Enfamil special care formula 20 cal/oz; Mead Johnson Nutritionals, Evansville, IN, USA) were started and increased as tolerated. Calculation of total caloric, carbohydrate, protein and fat intake included both enteral and parenteral nutrition using the manufacturers' specifications of nutritional content.
Statistical analyses
Data were analyzed using SPSS 12.0 for Windows (Chicago, IL). Univariate analyses utilized the Student's t-test, w 2 or MannWhitney U-test, as appropriate. Changes over time in weight, fluid, caloric, carbohydrate, protein and fat intake (including interaction between group and time) were analyzed using repeated measures ANOVA with BPD status as the between subject factor. In some analyses, factors (surfactant use, ventilator days, presence of PDA, PNS days, TPN days and sepsis; see Results) associated with BPD in univariate analyses were entered as covariates. Logistic regression was used to estimate odds ratios for developing BPD, depending on whether or not the infant regained BW; controlling for other confounding variables (vide supra). A P-value of <0.05 was considered statistically significant.
Results
Overall, out of the total of 306 infants, 137 infants developed BPD and 169 did not. Groups were similar in the use of antenatal steroids (73% at site A and 69% at site O) and other maternal characteristics ( Table 1 ). The infants in the BPD group, however, were of lower BW and GA and had lower Apgar scores (all Pp0.01), as depicted in Table 1 .
As shown in Table 2 , more infants in the BPD group had RDS, received surfactant, and had a PDA (all P<0.001). Through 36 weeks PMA, infants in the BPD group had received more days of ventilation, oxygen, TPN and PNS (all P<0.001). There was a higher incidence of sepsis in the BPD group versus the non-BPD group (P<0.001). No difference was found in the incidence of air leaks, IVH and PVL (Table 2) .
Remarkably, despite the inherent site differences, the maternal and neonatal characteristics in the infants developing BPD were very similar. To confirm this, we did a logistic regression analyses, with BPD as the outcome variable. As shown in Table 3 , BW, white race, PDA, surfactant use and sepsis, but not site, were significant predictors for BPD. 
Characteristics of infants with BPD M Akram Khan et al
We also analyzed the data by GA groups: 23 to 25 weeks (group 1), 26 to 28 weeks (group 2) and 29 to 32 weeks (group 3). While the effect of site was not significant in groups 1 and 3 (PX0.51), in group 2, the odds of getting BPD were 5.4 (95% CI: 1.4 to 21.3) times greater for site A than site O (P ¼ 0.017). Further analysis revealed that despite similar maternal and neonatal demographics, the duration of ventilation, oxygen, postnatal steroid use (all P<0.001) was much lower at one site, suggesting different approaches to mechanical ventilation in that GA category at the two sites.
On day 7 of life, weight loss was similar in babies who later went on to develop BPD and those who did not (Figure 1 ). After that time, however, the groups differed in weight gain (Pp0.001, BPD vs non-BPD, group by time), as depicted in Figure 1 with weight expressed as a percent of BW to 28 postnatal days. To determine if weight differences were due to reasons other than BPD, factors that differed in the BPD and non-BPD groups (surfactant use, ventilator days, PDA, PNS days, TPN days and sepsis) were entered as covariates in repeated measures ANOVA. The change in weight over time remained different between the groups (P ¼ 0.004).
Fluid intakes were similar between groups on days 1, 7 and 14; on days 21 and 28, the infants in the BPD group were receiving about 3% less fluids than the babies in the nonBPD group (P ¼ 0.16, group; P ¼ 0.033, time; P ¼ 0.008 group Â time; data not shown).
We then analyzed caloric intake in the first postnatal month. Babies who subsequently developed BPD received approximately 16% fewer calories in the first postnatal month as compared to babies who did not go on to develop BPD (P<0.001, group; P<0.001, time; P ¼ 0.003 group Â time; Figure 2 ). We then analyzed the components of this caloric intake, carbohydrates, proteins and fat. No infant received proteins or fat on the day of birth. Babies in the BPD group had a significantly less carbohydrate intake on the day of birth (P ¼ 0.005). As shown in Figure 3 , the BPD and non-BPD groups were similar in carbohydrate and protein intake on days 7, 14, 21 and 28 (PX0.17). Infants who subsequently developed BPD, however, received significantly fewer fat calories throughout their first postnatal month than infants who did not develop BPD (P<0.001).
The number of infants in each group that had regained BW by days 7, 14, 21 and 28 are shown in Table 4 . Logistic regression was used to estimate odds ratios for developing BPD if BW had not been regained by 7, 14, 21, or 28 days of life, controlling for the factors that differed in the BPD and non-BPD groups (surfactant use, ventilator days, PDA, PNS days, TPN days and sepsis). The odds of developing BPD in infants who had not regained BW by 14 days, were 2.30 (95% CI: 1.05 to 5.06) times that of those who had regained BW (P ¼ 0.038).
Additionally, we analyzed data of a subset population (n ¼ 40, in each group) matched for BW (±100 g) and GA (±1 week) in a sequential manner. Selected perinatal characteristics have been shown in Table 5 . There was also no difference among the groups as regards maternal race, PIH, chorioamnionitis, maternal drug use, gender, Apgar scores, NEC, IVH or PVL (data not shown). In Figure 1 Weight as a percentage of BW (which is 100%) in relation to postnatal age in infants who did or did not subsequently develop BPD. By repeated measures ANOVA, P ¼ 0.001, group; P<0.001, time; P ¼ 0.001, group Â time. Characteristics of infants with BPD M Akram Khan et al repeated measures ANOVA, weight gain (P ¼ 0.07), caloric intake (P ¼ 0.02) and, specifically, fat intake (P ¼ 0.03) was less over the first postnatal month in babies who subsequently developed BPD (data not shown). There was no overall difference in carbohydrate or protein intake (data not shown). After univariate analysis revealed a difference in ventilator and TPN days, multiple logistic regression analyses was performed. As before, babies who subsequently developed BPD gained less weight (P ¼ 0.073) and received fewer calories (P ¼ 0.004) than those who did not, after controlling for the above variables.
Discussion
This study confirms that BW, GA, white race, PDA, surfactant use and sepsis are important factors associated with BPD. These same factors have been reported by a number of studies from different countries, spanning a period of almost two decades. 3,10-13 Unlike others, 14 we did not find maternal chorioamnionitis as a significant contributor to BPD. This could potentially be because we used a different definition of chorioamnionitis.
A recent study looked at two NICUs with very different BPD rates to try and explain the reasons for this variation. 15 We set out with a very different goal -the selection of the NICUs was performed solely based on the location and the characteristics of the population they served. We anticipated some important differences, but once again, were impressed by the striking similarities of the factors associated with BPD in two different NICUs. As the data collection was almost completed at site A before initiation at site O, we felt that it would be appropriate to collect more recent data from site O. The mortality at site A from 1993 to 2000 was 15.5%, similar to that at site O (15.6%), over the same time period. The incidence of BPD (in infants <30 weeks GA) at site A over 1998 to 2000 was 39.3%, while it was 36% at site O during 1994 to 1997, similar to the rates reported in Table 1 . The fact that the overall BPD rates were not different supports the contention that not much headway has been made in improving this major cause for morbidity in premature infants, that can last up to adulthood. 
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The incidence of BPD was very similar at the two sites -43.8% at site A and 45.9% at site O (P ¼ 0.73), despite the fact that site A had younger babies (B1-week difference in GA). Despite that, site O had about half the ventilation and oxygen-use days and about one-quarter the number of PNS days, compared to site A (P<0.001). The above data suggests that differences exist in the management style of mechanical ventilation. When we grouped the babies in three GA categories, it was only in the 26 to 28 week category infants that these differences existed. Thus, one can speculate that if site A followed the management style of site O and decreased the duration of ventilation and oxygen, this would lead to decreased BPD and perhaps, less use of PNS. This would support the suggestion that by making changes in the initiation of mechanical ventilation, the incidence of BPD can perhaps be decreased. 15 Use of non-invasive ventilation with or without early surfactant administration may be helpful in this regard. [16] [17] [18] Multiple randomized controlled trials are underway to try and answer this question.
Increased fluid intake and decreased weight loss in the first week of life have been implicated in the pathogenesis of BPD by other investigators. [19] [20] [21] [22] The importance of weight loss having an impact on the pathogenesis of BPD is further highlighted by the fact that babies who had not regained BW on day 14 had higher odds (by a factor of 2.3) of developing BPD than those who had regained their BW, after controlling for confounding variables.
The issue of nutrition is somewhat linked with the fluid intake. To our knowledge, this is the first study to do such a detailed analysis of nutritional intake and growth vis-a`-vis BPD in two NICUs. We were surprised to note the uncanny similarities between the two units in terms of decreased nutrient, specifically fat intake. It is important to point out that before the initiation of this study, there had been no interaction between the two centers in terms of personnel or practice guidelines.
It is well known that infants with BPD have poor growth at 40 weeks PMA. At this age, infants with BPD have been shown to have a mean height and weight less than two standard deviations below that of term newborns. 23, 24 The degree of growth delay in infants with BPD is directly related to the severity and duration of the disease. 24 The cause of growth failure in such infants remains unclear. Most studies have evaluated infants after BPD has been well established. [25] [26] [27] Weinstein and Oh 25 reported increased oxygen consumption, implying elevated metabolic expenditure, as a cause of growth failure. They suggest that the growth failure can be overcome by improving nutritional intake. 25 Brunton et al.
26
showed accelerated growth in infants with BPD in response to protein, mineral and energy -enriched formula following discharge from the hospital. Kurzner et al. 27 showed that growth failure was not present in all infants with BPD, but it was clearly seen in infants who were smaller and sicker in the neonatal period. The same investigators also showed a linear correlation between serum albumin and body weights in infants with BPD, reflecting some degree of protein-calorie malnutrition.
BPD is a complex disorder with multiple factors involved in the pathogenesis, for example, immature lungs, ventilator-induced trauma and hyperoxia. 2 It has been speculated that inadequate early nutrition may contribute to the pathogenesis of BPD, by impeding lung repair in the first month of life. 28 It has been shown by us 29, 30 and others 31, 32 that growth failure in babies subsequently developing BPD can be detected in the first month of life. Wilson et al.
31 studied 22 infants (compared to 22 matched controls) and reported that babies with BPD weighed less at birth and had lower energy intakes on day 7, 10, 14, 28 and 56 of life 31. This study was performed in the presurfactant era and defined BPD as the need for supplemental oxygen at 28 days of life. 31 Detailed caloric intake was not reported. 31 Other investigators have shown that infants developing BPD consumed less protein and energy between postnatal weeks 2 and 4. 32 After they had achieved full enteral feeds and had similar protein-energy intakes, however, they grew as well as control infants. 32 This study looked at a small number of infants; excluded infants with BWs <750 g, and also used the 28-day definition of BPD. 32 The cause of growth failure in the extremely preterm infant who develops significant BPD remains unclear.
In the present study, we wanted to confirm and extend our previous observations 29, 30 (which was performed in a different population set) and to evaluate the reasons for growth failure in the first postnatal month in infants at risk for developing BPD at 36 weeks PMA.
The premature infant is extremely compromised in terms of available energy reserves. It should be obvious that inadequate nutritional support during the acute phase of RDS should be considered a major factor contributing to the eventual development of BPD. 33 Animal studies have revealed the additive effects of oxygen toxicity, decreased resistance to infection, impaired lung repair, and growth in the pathogenesis of BPD. 33 In our present study, we have illustrated that infants who subsequently develop BPD have poor weight gain in the first postnatal month. This growth failure is seen by day 14 and continues until at least day 28 ( Figure 1) . Two previous studies 31, 32 with smaller number of infants, also concluded that growth failure is established by 1 month of life. In our analyses, we controlled for factors (surfactant use, ventilator days, PDA, PNS days, TPN days and sepsis) that were different in the two groups and could have contributed to poor weight gain. Both the previous reports defined BPD as the need for supplemental oxygen at 28 days of life and did not take into account other factors known to contribute to the pathogenesis of BPD. Furthermore, the postsurfactant era study excluded infants with BW <750 g. 32 In that study, only four infants (out of 16) in the BPD group had need for supplemental oxygen at 36 weeks PMA, implying that most infants had mild BPD.
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Additionally, we have shown that total caloric intake was lower in babies who subsequently developed BPD (Figure 2) . We further analyzed the caloric intake in terms of carbohydrate, protein and fat intake. While carbohydrate intake was lower in babies on the day of birth, there was no subsequent difference among babies who developed BPD versus who did not. There was also no difference in the protein intake among the groups on days 7,14, 21 and 28. Additionally, in the subset population matched for BW and GA, the same relationship of poor growth and decreased total and fat calorie intake held true. This is in agreement with previous studies, 31, 32 that showed decreased energy intake in babies who had BPD (at 28 days of life) on days 10 and 14 31 and weeks 2 and 3.
32
Detailed caloric intake was not reported in the study by Wilson et al. 31 while the infants in the study by deRegnier et al. 32 had decreased protein intake.
In our study, there was significantly lower fat intake in the infants who subsequently developed BPD (Figure 3 ). The reason for the decreased fat intake in this study is unclear; it could possibly be related to the treating physicians' being cognizant of the fact that the lipid hydroperoxide content of some lipid emulsions may represent a clinically significant risk to premature infants, particularly those with pre-existing lung disease 34 or the infants being intolerant to higher intake of intravenous lipids. It is unlikely to be because of the infants being intolerant to lipids as serum triglycerides were not routinely monitored in these infants for hyperlipemia. The BPD group received far fewer fat calories in the first month of life. In such a scenario, it would be suggestive to increase early fat intake to see if it would have an impact on BPD. A study using early lipid infusion (starting <12 h of life) failed to protect infants from chronic lung disease and was terminated after <50% recruitment because of higher mortality in the 600 to 800 g BW category, increase in pulmonary hemorrhage and more infants needing supplemental oxygen on day 7. 35 In reply to a letter commenting on that report however, 36 the authors did not recommend withholding of lipid from the care of VLBW infants. Initiation of lipid intake could be attempted by day 3 or 4 of life to provide more calories.
The poor growth in these infants could be due to the higher caloric requirement known to exist in infants with more severe lung disease. Still, that does not do away from the fact, to begin with, the infants who went on to develop BPD received fewer fat calories.
The limitation of the study is its retrospective nature. However, to the best of our knowledge, this is the largest series of patients reported in the postsurfactant era looking at growth and nutritional intake in a population at risk for development of BPD. The strength of this study also lies in the fact that it corrects for confounding variables known to contribute to the pathogenesis of BPD. The results hold true even in the BW-and GA--matched population. We would like to suggest that nutrition is extremely important in the first postnatal month as it might provide the building blocks for the early healing of the lung with normal tissue rather than late repair with fibrous tissue.
In summary, we have confirmed that size (BW/GA), white race, PDA, surfactant use and sepsis are important factors associated with BPD. In addition, we have shown that there is decreased nutritional intake in the first postnatal month, specifically fat intake, and this may have an impact on the subsequent development of BPD. This data, however, still needs to be confirmed in other population groups, preferably in a prospective fashion. If the results of such studies hold true to our findings, such infants who are predisposed to BPD may be amenable to early aggressive nutritional intervention, especially optimal fat intake, to maximize their growth potential. Improving nutritional intake is certainly an achievable goal. 37 We speculate that such an approach would be beneficial in decreasing the incidence of BPD. While changes in ventilation management could potentially impact in the 26 to 28 weeks GA category of infants, for the smallest group, especially with the advent of 'new' BPD, genetic approaches should be paramount. 38 With the current explosion of genomic techniques and decreasing cost, this is now a viable option.
